Sandoz Canada has the necessary supply to ensure access to the S.O.S. Naloxone(TM) Hydrochloride Injection in response to the opioid crisis

Following the mention in certain media outlets regarding the unavailability of the Naloxone antidote against opioid overdoses, we wish to inform that -Sandoz Canada has the necessary supply to ensure access to S.O.S. Naloxone™ Hydrochloride Injection and it is available to all Canadian pharmacies that wish to obtain it. This injectable medicine is manufactured by Sandoz Canada at its Boucherville facility in Quebec and is available without a prescription at the pharmacy counter. Sandoz Canada is known for having the most reliable supply chain in the industry, and the company’s inventories can supply the market and meet the growing needs.

S.O.S Naloxone^TM Hydrochloride Injection may be administered by a bystander, by family, friends or a healthcare professional to a patient who is experiencing or suspected of overdosing on opioids, reversing the effects before medical aid arrives. Emergency medical assistant should still be requested immediately when an opioid overdose is suspected.

A pamphlet with patient information, as well as step-by-step instructions and illustrations sur the administration process is offered with the product. A demonstration video is equally available explaining the correct way of administering Naloxone. To view it, click here (external link).

S.O.S. Naloxone^TM Hydrochloride Injection is available in ampoules each containing 0.4 mg / mL naloxone hydrochloride.

Sandoz is discovering new ways to improve and extend people’s lives. We pioneer novel approaches to help people access high-quality medicine. This is how we contribute to improving society’s ability to support growing healthcare needs and costs.

If you have any questions, do not hesitate to contact us.

The Communications Team

Sandoz Canada